Literature DB >> 10442725

Evaluation of superior oblique weakening procedures.

P Sharma1, S Khokhar.   

Abstract

PURPOSE: To evaluate two superior oblique weakening procedures, silicon expander (SE), and translational recession (TR), and their effects on correction of "A" pattern, vertical deviation in adduction and dorsoadduction, superior oblique overaction, and torsion.
METHOD: In a prospective, institution-based study, 32 eyes of 16 patients having bilateral superior oblique overaction with significant "A" pattern (>10 prism diopters [delta]) were evaluated. The parameters studied were: change in "A" pattern; effect on vertical deviation in adduction and dorsoadduction; superior oblique overaction; and torsion. 95% reduction in "A" pattern with SE and 92% reduction with TR, indicating equal effect in collapse of "A" phenomenon (p=0.78). The extorsion produced by TR was more than that produced by SE (p=0.001).
CONCLUSIONS: Both the SE and TR procedures offered controlled weakening of the superior oblique and caused a 95% and 92% reduction in the "A" pattern. The latter procedure caused a marked extorsional change, three times that which resulted from SE. Both the procedures leave residual superior oblique overaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10442725     DOI: 10.3928/0191-3913-19990701-07

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  2 in total

1.  Evaluation of subjective and objective cyclodeviation following oblique muscle weakening procedures.

Authors:  Pradeep Sharma; S Thanikachalam; Sachin Kedar; Rahul Bhola
Journal:  Indian J Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 1.848

2.  Management of simultaneous ocular elevation and depression deficit in patients after reconstruction surgery for orbital floor fracture.

Authors:  Piotr Loba; Agata Joanna Ordon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-04-15       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.